Patents by Inventor Mark Lagacé

Mark Lagacé has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compounds for modulating male fertility
    Patent number: 6797473
    Abstract: The invention features methods and reagents useful for the treatment of excessive or insufficient apoptosis in cells, and, particularly, in germ-line cells. The invention is useful in treating testicular cancers, cancers of germ-line cells, cancers in non-germ-line cell tissues, infertility (e.g., male infertility), and for birth control (e.g., male birth control).
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: September 28, 2004
    Assignee: University of Ottawa
    Inventors: Robert G. Korneluk, Mark Lagacé
  • Methods and compounds for modulating male fertility
    Patent number: 6331412
    Abstract: The invention features novel methods and reagents useful for the treatment of excessive or insufficient apoptosis in cells, and, particularly, in germ-line cells. The invention is useful in treating testicular cancers, cancers of germ-line cells, cancers in non-germ-line cell tissues, infertility (e.g., male infertility), and for birth control (e.g., male birth control).
    Type: Grant
    Filed: January 29, 1999
    Date of Patent: December 18, 2001
    Assignee: University of Ottawa
    Inventors: Robert G. Korneluk, Mark Lagacé